TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,507,851 | +10106.8% | 24,527,801 | +2035.0% | 0.01% | – |
| Q2 2023 | $759,374 | -84.6% | 1,148,827 | -81.4% | 0.00% | – |
| Q1 2023 | $4,924,922 | -32.0% | 6,174,676 | +92.7% | 0.00% | -100.0% |
| Q4 2022 | $7,243,124 | +14.2% | 3,204,922 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $6,342,000 | -48.3% | 3,285,783 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $12,260,000 | -42.9% | 3,295,689 | +0.0% | 0.00% | -50.0% |
| Q1 2022 | $21,483,000 | -56.9% | 3,294,821 | -23.0% | 0.00% | -50.0% |
| Q4 2021 | $49,868,000 | -53.5% | 4,280,494 | -25.7% | 0.00% | -55.6% |
| Q3 2021 | $107,226,000 | -11.1% | 5,758,674 | +1.2% | 0.01% | 0.0% |
| Q2 2021 | $120,577,000 | +4.9% | 5,687,616 | +0.4% | 0.01% | -10.0% |
| Q1 2021 | $114,984,000 | -22.2% | 5,664,215 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $147,862,000 | +64.1% | 5,664,215 | +34.6% | 0.01% | +44.4% |
| Q3 2020 | $90,087,000 | – | 4,207,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |